Insider Selling: Proto Labs (NYSE:PRLB) CFO Sells 5,000 Shares of Company Stock

Key Points

• Proto Labs CFO Daniel Schumacher sold 5,000 shares at an average price of $95.32, generating $476,600. The transaction was made under a pre-arranged Rule 10b5-1 plan and reduced his direct ownership by 12.49% to 35,019 shares.
• Proto Labs shares traded near their 52-week high at $96.19, with a $2.30 billion market capitalization and a P/E ratio of 76.95. The company recently beat quarterly earnings and revenue expectations, reporting $0.60 EPS and $149.34 million in revenue.
• Analyst sentiment remains positive, with a consensus “Buy” rating and an average price target of $89.00. Institutional investors own approximately 84.54% of the company’s stock.

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) CFO Daniel Schumacher sold 5,000 shares of the business's stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $95.32, for a total transaction of $476,600.00. Following the sale, the chief financial officer directly owned 35,019 shares of the company's stock, valued at approximately $3,338,011.08. This trade represents a 12.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Schumacher also recently made the following trade(s):

• On Thursday, September 17th, Daniel Schumacher sold 4,900 shares of Proto Labs stock. The shares were sold at an average price of $85.21, for a total value of $417,529.00.
• On Wednesday, September 16th, Daniel Schumacher sold 100 shares of Proto Labs stock. The stock was sold at an average price of $85.00, for a total value of $8,500.00.

Proto Labs Stock Performance

PRLB traded up $3.21 during midday trading on Friday, reaching $96.19. 255,948 shares of the company were exchanged, compared to its average volume of 198,289. The stock has a market capitalization of $2.30 billion, a P/E ratio of 76.95 and a beta of 1.42. Proto Labs, Inc. has a one year low of $45.10 and a one year high of $96.92. The stock's 50-day simple moving average is $82.48 and its 200 day simple moving average is $73.55.

Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.07. The firm had revenue of $149.34 million during the quarter, compared to analysts' expectations of $144.53 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business's revenue for the quarter was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, research analysts anticipate that Proto Labs, Inc. will post 1.46 earnings per share for the current year.

Institutional Trading of Proto Labs

Several institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. bought a new stake in Proto Labs in the 2nd quarter valued at $317,581,000. American Capital Management Inc. bought a new position in shares of Proto Labs in the second quarter valued at about $50,524,000. Renaissance Technologies LLC lifted its stake in shares of Proto Labs by 5.4% during the 1st quarter. Renaissance Technologies LLC now owns 520,251 shares of the industrial products company's stock worth $29,665,000 after buying an additional 26,700 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Proto Labs by 0.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 463,780 shares of the industrial products company's stock worth $26,445,000 after buying an additional 3,162 shares during the period. Finally, S Squared Technology LLC acquired a new position in Proto Labs in the 2nd quarter valued at about $23,484,661. Institutional investors own 84.54% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Weiss Ratings lowered shares of Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, September 18th. Needham & Company LLC upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price for the company in a report on Monday, August 3rd. Zacks Research raised Proto Labs from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 6th. Wall Street Zen downgraded Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. Finally, Benchmark boosted their price target on shares of Proto Labs from $70.00 to $91.00 and gave the stock a "buy" rating in a research report on Thursday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company. According to MarketBeat, Proto Labs presently has a consensus rating of "Buy" and an average price target of $89.00.

About Proto Labs

Proto Labs, Inc NYSE: PRLB, doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.

The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.